Rigel Pharmaceuticals
RIGL
#6656
Rank
S$0.97 B
Marketcap
S$51.72
Share price
-2.67%
Change (1 day)
-5.09%
Change (1 year)

Earnings for Rigel Pharmaceuticals (RIGL)

Earnings in 2026 (TTM): S$0.11 Billion

According to Rigel Pharmaceuticals's latest financial reports the company's current earnings are S$0.27 Billion. In 2025 the company made an earning of S$0.16 Billion, an increase over its 2024 earnings that were of S$33.9 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Rigel Pharmaceuticals from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) S$0.11 B-29.31%
2025 S$0.16 B391.35%
2024 S$33.9 M-244.27%
2023 -S$23.51 Million-66.79%
2022 -S$70.78 Million340.73%
2021 -S$16.06 Million-56.15%
2020 -S$36.63 Million-57.34%
2019 -S$85.87 Million-7.66%
2018 -S$92.99 Million-9.47%
2017 -S$0.11 Billion24.46%
2016 -S$82.53 Million23.63%
2015 -S$66.75 Million-43.29%
2014 -S$0.12 Billion2.5%
2013 -S$0.12 Billion
2010 S$48.83 M-133.97%
2009 -S$0.15 Billion-18.49%
2008 -S$0.18 Billion71.91%
2007 -S$0.11 Billion84.74%
2006 -S$55.54 Million-10.17%
2005 -S$61.82 Million-15.73%
2004 -S$73.36 Million39.29%
2003 -S$52.67 Million10.3%
2002 -S$47.76 Million48.3%
2001 -S$32.2 Million-2.13%
2000 -S$32.91 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
S$14.25 B 11,994.42%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$19.46 B 16,412.19%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
-S$0.15 Billion-220.73%๐Ÿ‡บ๐Ÿ‡ธ USA
ChemoCentryx
CCXI.defunct
-S$0.17 Billion-242.92%๐Ÿ‡บ๐Ÿ‡ธ USA